Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoBio Designs is a biotechnology company based in Des Moines, Iowa, that has developed a proprietary platform for the rapid and cost-effective detection of genetic markers. Its core technology, the C-SAND (Colorimetric-Specific Nucleic Acid Detection) platform, utilizes nanoparticles to identify specific DNA or RNA sequences without the need for laboratory-based amplification like PCR. The platform provides a simple colorimetric readout, enabling high-accuracy genetic testing to be performed in minutes at the point of use. While the company's current commercial focus is on agricultural applications, such as seed trait verification and plant pathogen detection, the technology is being adapted for human healthcare diagnostics and environmental monitoring. NanoBio Designs aims to democratize genetic testing by making it accessible outside of traditional laboratory settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NanoBioDesign.